GHK-Cus documented interaction with 4,000+ human genes, antioxidant pathway upregulation demonstrated in Pickarts 2012 and 2015 studies (PMID: 28386432), and wound healing acceleration in diabetic ulcer models extend its research relevance far beyond the cosmetic skin applications UK suppliers exclusively market
An Exciting New Frontier Dihexa Results Because each body and brain are unique, and we are learning so much about the benefits of this innovative new treatment, results may vary
Rights and permissions About this article Cite this article Traish, A.M., Melcangi, R.C., Bortolato, M
Reported side effects are rare and typically mild temporary redness or irritation at the application site, usually resolving quickly No documented systemic toxicity in research literature at typical therapeutic doses European Medicines Agency and independent research groups rate it as well-tolerated Compatible with most standard skincare routines when used with appropriate spacing from incompatible actives Contraindications and cautions Known sensitivity or allergy to copper compounds: avoid use Active skin infections or open wounds at the injection site: delay treatment Pregnancy and breastfeeding: insufficient safety data
That's a distinction that gets missed more than you'd think